These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 29193649)
21. Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway. Sun B; Dong C; Lei H; Gong Y; Li M; Zhang Y; Zhang H; Sun L Chem Biol Interact; 2018 Oct; 294():28-33. PubMed ID: 30130526 [TBL] [Abstract][Full Text] [Related]
23. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor. Greenberger S; Bischoff J Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006460. PubMed ID: 22229118 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of plasma and urinary levels of vascular endothelial growth factor and matrix metalloproteinase-9 in patients with infantile hemangioma. Rotter A; Lima XT; Oliveira ZNP Int J Dermatol; 2021 Oct; 60(10):1263-1269. PubMed ID: 33959962 [TBL] [Abstract][Full Text] [Related]
25. Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres. Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C Oncol Rep; 2018 Jan; 39(1):109-118. PubMed ID: 29192323 [TBL] [Abstract][Full Text] [Related]
26. Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents? de Wild SR; Moyakine AV; van der Vleuten CJM Pediatr Dermatol; 2019 Nov; 36(6):958-960. PubMed ID: 31566792 [TBL] [Abstract][Full Text] [Related]
27. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306 [TBL] [Abstract][Full Text] [Related]
29. [What's new about infantile hemangiomas?]. Dreyfus I; Maza A; Mazereeuw-Hautier J Arch Pediatr; 2013 Jul; 20(7):809-16. PubMed ID: 23628116 [TBL] [Abstract][Full Text] [Related]
30. [Hemangioma. New aspects of pathogenesis, differential diagnosis and therapy]. Höger PH Hautarzt; 2012 Feb; 63(2):112-20. PubMed ID: 22349036 [TBL] [Abstract][Full Text] [Related]
31. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Reddy KK; Blei F; Brauer JA; Waner M; Anolik R; Bernstein L; Brightman L; Hale E; Karen J; Weiss E; Geronemus RG Dermatol Surg; 2013 Jun; 39(6):923-33. PubMed ID: 23458381 [TBL] [Abstract][Full Text] [Related]
32. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions. Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of haemangiomas of infancy with propranolol; good results, few side effects]. Hermans DJ; Ottenhof MJ; Wijnen MH; van Beynum IM; van der Horst CM; van der Vleuten CJ Ned Tijdschr Geneeskd; 2011; 155(40):A3482. PubMed ID: 21988755 [TBL] [Abstract][Full Text] [Related]
34. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064 [TBL] [Abstract][Full Text] [Related]
35. Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor. Ozeki M; Nozawa A; Hori T; Kanda K; Kimura T; Kawamoto N; Fukao T Pediatr Int; 2016 Nov; 58(11):1130-1135. PubMed ID: 26991797 [TBL] [Abstract][Full Text] [Related]
36. Infantile hemangioma: the common and enigmatic vascular tumor. Holm A; Mulliken JB; Bischoff J J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618963 [TBL] [Abstract][Full Text] [Related]
37. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas. Moyakine AV; Herwegen B; van der Vleuten CJM J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436 [TBL] [Abstract][Full Text] [Related]
38. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Ji Y; Chen S; Xu C; Li L; Xiang B Br J Dermatol; 2015 Jan; 172(1):24-32. PubMed ID: 25196392 [TBL] [Abstract][Full Text] [Related]
39. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients. Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601 [TBL] [Abstract][Full Text] [Related]
40. Is Infantile Hemangioma a Neuroendocrine Tumor? Kaulanjan-Checkmodine P; Oucherif S; Prey S; Gontier E; Lacomme S; Loot M; Miljkovic-Licina M; Cario M; Léauté-Labrèze C; Taieb A; Moisan F; Rezvani HR Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]